EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Special Issue “Host Targeted Therapeutics Against Virus Infections”

Stephan Pleschka iD

Viruses · 25.11.2024 · 16 (12) · 1825

DOI: 10.3390/v16121825 ↗

Kurz gefasst

Editorial in der Zeitschrift Viruses, online erschienen am 25.11.2024. Verfasst von Stephan Pleschka. Beteiligte Einrichtung: Institute of Medical Virology, Justus Liebig University Giessen, 35392 Giessen, Germany. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antiviral Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic, along with the emergence and sustained transmission of highly pathogenic avian influenza viruses (H5N1) in U [...]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Antiviral AgentsHumansAnimalsInfluenza, HumanVirus DiseasesInfluenza A Virus, H5N1 SubtypeCOVID-19 Drug Treatment

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Institute of Medical Virology, Justus Liebig University Giessen, 35392 Giessen, Germany.
  • German Center for Infection Research (DZIF), Partner Site Giessen, 35392 Giessen, Germany.

ORCID-Profile: Stephan Pleschka

Zitieren

APA

Pleschka, S. (2024). Special Issue “Host Targeted Therapeutics Against Virus Infections”. Viruses, 16(12), 1825. https://doi.org/10.3390/v16121825

Vancouver

Pleschka S. Special Issue “Host Targeted Therapeutics Against Virus Infections”. Viruses. 2024;16(12):1825. doi:10.3390/v16121825

BibTeX
@article{Pleschka2024,
  author = {Pleschka, Stephan},
  title = {Special Issue “Host Targeted Therapeutics Against Virus Infections”},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {12},
  pages = {1825},
  doi = {10.3390/v16121825}
}
Kostenlos starten →